4D Molecular Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary

4D Molecular Therapeutics

14/11/2024 04:00

* 4D Molecular Therapeutics Inc  FDMT.OQ  reported a
quarterly
adjusted loss of 79 cents​​ per share for the quarter ended
September 30, lower than the same quarter last year, when the
company reported EPS of -24 cents.  The mean expectation of
ten analysts for the quarter was for a loss of 70 cents per
share. Wall Street expected results to range from -80 cents
to -63 cents per share.
    * Revenue fell 100% to $3.00 thousand from a year ago;
analysts
expected $558.29 thousand. 
    * 4D Molecular Therapeutics Inc's reported EPS for the
quarter was
a loss of 79 cents​.
    * The company reported a quarterly loss of $43.84 million.
    * 4D Molecular Therapeutics Inc shares had fallen by 27.2%
this
quarter and lost 61.2% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 9 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for 4D Molecular
Therapeutics Inc is 40.00 
This summary was machine generated from LSEG data November 14 at
04:00 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.70          -0.79          Missed
 Jun. 30 2024      -0.70          -0.63          Beat
 Mar. 31 2024      -0.74          -0.66          Beat
 Dec. 31 2023      -0.74          -0.75          Missed